Saavedra, Genesa .

HRN: 06-27-30  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/19/2023
CEFUROXIME 1.5GM (VIAL)
12/19/2023
12/19/2023
IV
1.5gm
Ld
Eclampsia For CS
Waiting Final Action 
12/19/2023
CEFUROXIME 750MG (VIAL)
12/19/2023
12/21/2023
IV
1.5g
Q8 X 6 Doses
S/P LTCS
Waiting Final Action 
12/19/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/19/2023
12/21/2023
IV
500mg
Q8 X 6 Doses
S/P LTCS With BTL
Waiting Final Action 
12/20/2023
CEFUROXIME 500MG (TAB)
12/20/2023
12/27/2023
PO
500 Mg Tab
BID
S/P LSTCS
Waiting Final Action 
12/20/2023
METRONIDAZOLE 500MG (TAB)
12/20/2023
12/27/2023
PO
500 Mg Tab
TID
S/P LSTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: